000			01385 a2200385 4500
005			20250512202026.0
264		0	_c19840107
008			198401s 0 0 eng d
022			_a0165-1781
024	7		_a10.1016/0165-1781(83)90003-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aNybäck, H
245	0	0	_aCerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers. _h[electronic resource]
260			_bPsychiatry research _cAug 1983
300			_a301-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aCerebral Ventriculography
650	0	4	_aFemale
650	0	4	_aHomovanillic Acid _xcerebrospinal fluid
650	0	4	_aHumans
650	0	4	_aHydroxyindoleacetic Acid _xcerebrospinal fluid
650	0	4	_aMale
650	0	4	_aMethoxyhydroxyphenylglycol _xcerebrospinal fluid
650	0	4	_aPsychotic Disorders _xcerebrospinal fluid
650	0	4	_aSchizophrenia _xcerebrospinal fluid
650	0	4	_aTomography, X-Ray Computed
700	1		_aBerggren, B M
700	1		_aHindmarsh, T
700	1		_aSedvall, G
700	1		_aWiesel, F A
773	0		_tPsychiatry research _gvol. 9 _gno. 4 _gp. 301-8
856	4	0	_uhttps://doi.org/10.1016/0165-1781(83)90003-3 _zAvailable from publisher's website
999			_c6196843 _d6196843